Biopharma News : Biopharma and Pharma news from all around the world :
- Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
- Dr. Mikael Dolsten Named to Agilent Board of Directors
- Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program
- Astex Pharmaceuticals Presents Overall Survival Data From ASCERTAIN Phase 3 Study of Oral Hypomethylating Agent INQOVI® (decitabine and cedazuridine) in MDS and CMML at International Congress on Myelodysplastic Syndromes
- ModivCare to Present at Deutsche Bank’s 29th Annual Leveraged Finance Conference
- Novālent is Now Available at Walmart Inc.
- ACES Announces Formation of Clinical Advisory Board
- The College of American Pathologists Hosts 2021 Annual Meeting: September 25-28
- Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug Uproleselan Published in BLOOD
- Carevive Introduces Carevive SMART Data to Highlight the Real-world Oncology Patient Experience
- Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies
- PsychoGenics Chief Innovation Officer Honored for Scientific Excellence
- Europe Diabetic Neuropathy Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Sales, Drug Forecasts and Market Shares 2018-2026 – ResearchAndMarkets.com
- Europe Bone Cancer Market and Competitive Landscape Report 2021-2026 – ResearchAndMarkets.com
- Poxel Reports Financial Results for First Half 2021 and Provides a Corporate Update
- Fluence by OSRAM Experts Join Speaker Lineups at Global Horticulture and Cannabis Conferences This Fall
- Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress
- United States Biobanks (Population Based v/s Disease) Markets, Competition Forecast & Opportunities, 2021-2026 – ResearchAndMarkets.com
- New Product Launch: Pharmaceutical Strategies Group Launches Artemetrx Rebate Monitor
- bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
- Valent BioSciences and Kansas State University Sign Collaborative Agreement for Soil Health Research Initiative with Dr. Charles W. Rice
- Elligo Health Research® and ClinEdge Join in Major Expansion
- PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
- Cryosa Closes $21.5 Million Series B Funding Round to Advance Minimally Invasive Obstructive Sleep Apnea Treatment
- Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analysts
- GoodRx Launches GoodRx Health, A Next-Generation Online Health Resource
- IDC MarketScape Positions Model N as a Leader in B2B Price Optimization and Management Applications
- Dr. Jason Kirby Joins Landmark Recovery as New Chief Medical Officer
- Neurolief Announces First Patient Enrolled in Clinical Study Evaluating Its Brain Neuromodulation System in Treating Major Depressive Disorder
- Aarvik Therapeutics Appoints Dr. Richard Scheller to Board of Directors, Dr. Melissa Starovasnik to Scientific Advisory Board, and Announces Scientific Team
Biotech – Biopharma News!
- Abivax presents first-half 2021 financial results and operations update
- Original-Research: Formycon (von First Berlin Equity Research GmbH)
- Formycon Publishes Half-Year Results for 2021
- Disruptive antibacterial silver coating technology: Very good results after use of 3 silver-coated implants as positive indication for start of human clinical study in Q4/21
- Relief’s Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Data Published in Peer Reviewed Journal, Nutrients, Indicating Additional Potential Benefits of Its Physiomimic(TM) Technology
- Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress (news with additional features)
- M1 Kliniken AG continues growth course
- Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)
- DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS
- Vita 34 AG launches voluntary public exchange offer for PBKM shares
- Biotest AG: Takeover Offer: Grifols S.A. to make a voluntary public takeover offer for the shares of Biotest AG
- PAION AG ANNOUNCES INITIATION OF PIVOTAL STUDY OF REMIMAZOLAM (BYFAVO(R)) IN PEDIATRIC PROCEDURAL SEDATION
- aap Implantate AG significantly raises EBITDA forecast for financial year 2021
- SynBiotic SE: Christian Angermayer now largest shareholder with circa 45%
- PharmaSGP: Product portfolio further expanded and internationalisation driven forward in H1 2021
- Newron announces Half-Year 2021 results
- AEVIS VICTORIA SA: Half-year results 2021 – EBITDAR margin surges to 23.4%
- Newron announces Half-Year 2021 results
- BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives
- BRAIN Biotech AG: BRAIN Biotech AG has successfully completed 10% cash capital increase from authorised capital with exclusion of statutory subscription rights
- PharmaSGP Holding SE raises forecast for FY 2021 following completion of acquisition of OTC brand portfolio
- BRAIN Biotech AG resolves on a cash capital increase from authorised capital
- BRAIN Biotech AG resolves on a 10% cash capital increase from authorised capital with exclusion of statutory subscription rights.
- Formycon’s COVID-19 drug FYB207 Wins Prestigious Pharma Trend Image & Innovation Award 2021
- Biotest AG: Biotest announces the new Renate & Hans Schleussner Award for scientific research
- Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis
- DEFENCE THERAPEUTICS SUCCESS IN TESTING IT’S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODEL
- APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemia
- Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress
- Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million
- Brooklyn ImmunoTherapeutics Reports Inducement Grants
- Medicenna Appoints Dr. John H. Sampson to its Board of Directors
- vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
- Treace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual Meeting
- Ocugen, Inc. to Participate in Fireside Chat at the Cantor Virtual Global Healthcare Conference
- Stryker to host conference call on October 28, 2021
- Medolife Rx Launches Ad Campaign With Tony Hawk, Sees Immediate Positive Results
- Alpha Cognition Announces Pricing of Public Offering
- Meru Health Raises $38M Series B Financing to Transform the Way Mental Health Care is Provided, Make High Quality, Effective Care Available to All Online
- Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
- BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
- Immuron planned Acquisition of R&D Vaccine Company
- Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com
- Allarity Therapeutics and Lonza Collaborate to Manufacture Dovitinib, a Renal Cell Carcinoma Candidate
- Inventiva completes sale of $30 million through its ATM program to existing and new specialized institutional investors
- Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease
- Nicox Announces Results from the NCX 4251 Phase 2b Mississippi Blepharitis Trial
- Santhera and ReveraGen to Present Phase 2a/2b Efficacy and New Safety Data with Vamorolone at Forthcoming Conferences
- Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
- Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
- Hyloris Appoints Jean-Luc Vandebroek as Chief Financial Officer
- Press release Biocartis Group NV: Biocartis Announces Restart of its High-Throughput Cartridge Manufacturing Line
- Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.
- UPDATE – New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS
- Immunocore announces publication of phase 3 data comparing tebentafusp with investigator’s choice in The New England Journal of Medicine
- SomaLogic Announces Upcoming Conference Participation and Analyst Meeting
- Blueberries Announces Webcast Instructions for its Annual General and Meeting (“AGM”)
- Alpha Cognition Announces Overnight Marketed Offering
- Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021
- After safety review The Connection study is now again open to recruit the smallest infants.
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News